ClinConnect ClinConnect Logo
Search / Trial NCT06831019

The ROAR Study: Reactive Oxygen Species and Reproduction

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Feb 13, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Oxidative Stress Ovarian Aging

ClinConnect Summary

The ROAR Study is looking into how oxidative stress, which is an imbalance between free radicals and antioxidants in the body, affects fertility, particularly in women undergoing in vitro fertilization (IVF). The study aims to understand how levels of oxidative stress in both women and their male partners relate to the quality of eggs and embryos. By measuring these levels in the fluid surrounding the eggs and in blood samples, the researchers hope to see how they impact the chances of a successful pregnancy through IVF.

To participate in this study, women must be between the ages of 18 and 43 and planning to undergo a specific type of IVF called blastocyst culture for genetic testing. Their male partners should also be at least 18 years old. It's important to note that women over 43 or those planning different types of IVF procedures will not be eligible. Participants can expect to provide samples and undergo assessments related to their fertility, helping researchers gain valuable insights that could improve IVF outcomes for couples facing infertility challenges.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Female age 18-43 years
  • 2. Subjects planning blastocyst culture for preimplantation genetic screening (PGS) for aneuploidy.
  • 3. Male partners 18 years of age or older.
  • Exclusion Criteria:
  • Female partner age 44 or older
  • Planning fresh transfer (hybrid PGS cycle)
  • Cleavage stage biopsy

About University Of California, San Francisco

The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.

Locations

San Francisco, California, United States

Patients applied

0 patients applied

Trial Officials

Mitchell Rosen, MD

Principal Investigator

University of California, San Francisco

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported